Emergent Biosolutions: Q3 Earnings Snapshot

GAITHERSBURG, Md. (AP) _ Emergent Biosolutions Inc. (EBS) on Tuesday reported a loss of $75.7 million in its third quarter.

The Gaithersburg, Maryland-based company said it had a loss of $1.52 per share. Losses, adjusted for non-recurring costs, were $1.27 per share.

The biopharmaceutical company posted revenue of $240 million in the period.

Emergent Biosolutions expects full-year revenue in the range of $1.05 billion to $1.1 billion.

GAITHERSBURG, Md. (AP) _ Emergent Biosolutions Inc. (EBS) on Tuesday reported a loss of $75.7 million in its third quarter.

The Gaithersburg, Maryland-based company said it had a loss of $1.52 per share. Losses, adjusted for non-recurring costs, were $1.27 per share.

The biopharmaceutical company posted revenue of $240 million in the period.

Emergent Biosolutions expects full-year revenue in the range of $1.05 billion to $1.1 billion.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on EBS at https://www.zacks.com/ap/EBS

Copyright © 2022 . All rights reserved. This website is not intended for users located within the European Economic Area.